Primary ovarian failure, Failure of genital response, Sexual Dysfunction, Physiological
Conditions
Interventions
GROUP A (20 women)
Eight electrotherapy sessions, divided into a frequency of twice a week, individually, with the application of the bipolar interferential current using the Endophasys NMS-0501 appar
MPA: 50 Hz
Slope: 1/1
Intensity will be set according to each patient, maintaining at the point where the patient reports a feeling of "strong but comfortable".
Therapy time: 20 minutes
Placement of the electrod
Drug
Other
E02.331
E01.370.405.255
E05.318.308.980
G06.591.875
Sponsors
Universidade Estadual de Campinas
Universidade Estadual de Campinas
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with Premature ovarian Insufficiency for one year or more; in use of systemic hormone therapy three months or more; Age between 18 and 50 years, sexually active; Presenting sexual activity for at least six months with at least one intercourse in the last four weeks
Exclusion criteria
Exclusion criteria: Women with complaints of sexual dysfunction exclusively related to the absence of desire; Use of copper IUDs, pacemakers, or some type of metal implant in the lumbar spine or hip region; Women with an acute infectious process in the vulvar region, genital ulcer or using medications that may cause mucositis; Women undergoing systemic or acute localizes allergic conditions; Women who are known to have a chronic degenerative disease, chronic immunosuppression, pelvic or spine deformity, neoplastic diseases; Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LUBRICATION - Women with premature ovarian failure (IOP) will experience a significantly greater improvement in vaginal lubrication after the use of interferential current in relation to the use of topical estrogen. Based on the questionnaire female sexual function index (FSFI) with score (0 to 6) for the lubrication domain, 4 weeks after starting treatment with maintenance for at least 4 weeks after the end of the treatment.;SEXUAL FUNCTION - Women with premature ovarian insufficiency (IOP) will have a significantly greater improvement in sexual function after the use of interferential current in relation to the use of topical estrogen. Based on the questionnaire female sexual function index (FSFI) score (1.2 to 36) with a cut of at 26.55 for sexual dysfunction, 4 weeks after starting treatment and maintaining improvement for at least 4 weeks after the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| MICROBIOME- The microbiome of women with premature ovarian failure in the use of hormonal Therapy will not be affected by the use of Interferential Current or topical Estrogen. (Evaluated through the collection of vaginal secretion for vaginal flora analysis by means of pyosequencing) - Vaginal microbiome for the detection of bacterial end fungal content in the vagina. ;PELVIC FLOOR - The studied women will have a better pelvic floor musculature function after the use of interferential current in relation to those who use topical estrogen. Evaluated through electromyography (Miotec Miotool apparatus) with improved tone, maximum strength and endurance. After 4 weeks of treatment. | — |
Countries
Brazil
Contacts
Public ContactCristina Benetti-Pinto
Universidade Estadual de Campinas
Outcome results
None listed